Cite
Pharmacological treatment options for osteoarthritis: focus on symptomatic slow-acting drugs for osteoarthritis (SYSADOA) and individual patient characteristics: Resolution of the International Expert Meeting
MLA
A. M. Lila, et al. “Pharmacological Treatment Options for Osteoarthritis: Focus on Symptomatic Slow-Acting Drugs for Osteoarthritis (SYSADOA) and Individual Patient Characteristics: Resolution of the International Expert Meeting.” Современная Ревматология, vol. 13, no. 4, Oct. 2019, pp. 143–47. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b58a231beff1a16f8dfcb08c597a8396&authtype=sso&custid=ns315887.
APA
A. M. Lila, L. I. Alekseeva, A. R. Babaeva, I. Z. Gaydukova, G. Gandolini, E. V. Zonova, R. Capelli, A. E. Karateev, S. S. Kopenkin, N. A. Martusevich, O. B. Nesmeyanova, E. N. Otteva, F. Rannuе, T. A. Raskina, M. L. Sukhareva, E. A. Taskina, N. V. Chichasova, & S. P. Yakupova. (2019). Pharmacological treatment options for osteoarthritis: focus on symptomatic slow-acting drugs for osteoarthritis (SYSADOA) and individual patient characteristics: Resolution of the International Expert Meeting. Современная Ревматология, 13(4), 143–147.
Chicago
A. M. Lila, L. I. Alekseeva, A. R. Babaeva, I. Z. Gaydukova, G. Gandolini, E. V. Zonova, R. Capelli, et al. 2019. “Pharmacological Treatment Options for Osteoarthritis: Focus on Symptomatic Slow-Acting Drugs for Osteoarthritis (SYSADOA) and Individual Patient Characteristics: Resolution of the International Expert Meeting.” Современная Ревматология 13 (4): 143–47. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b58a231beff1a16f8dfcb08c597a8396&authtype=sso&custid=ns315887.